期刊文献+

转化医学与肿瘤研究现状 被引量:3

原文传递
导出
摘要 转化医学的核心思想是促进基础医学研究向临床应用的转化,同时根据临床的需求提出前瞻性的应用基础研究方向。在后基因组时代,如何在转化医学引领下,将实验室发现的有意义的结果、分子生物学理论和技术运用到临床,使肿瘤研究得到更快更好的发展,是我们亟须解决的问题。本文就转化医学在肿瘤研究中发挥的作用,如生物标记物在肿瘤诊疗中的运用、药物研发模式的转变及肿瘤诊疗的信息化水平不断提高等进行探讨。
出处 《中华医学科研管理杂志》 2011年第3期216-216,F0003,F0004,共3页 Chinese Journal of Medical Science Research Management
  • 相关文献

参考文献22

  • 1Cunliffe and Frank Ltd.The war on cancer[M/CD].New York,Cunliffe and Frank Ltd,1997.
  • 2Cohen MM,Diamond JM.Mdical research Are we losing the war on cancer?.Nature,1986,323(6088):488-489.
  • 3Jemal A,Siegel R,Ward E,et al.Cancer statistics,2007.CACancer J Clin,2007,57(1):43-66.
  • 4Adams JU.Building the bridge from bench to bedside.Nature Reviews Drug Discovery,2008(7):463-464.
  • 5Cullen JP,Glynn C,Murtagh E,et al.Auditing a new lung cancer service.Ir Med J,2004,97(9),281.
  • 6McDavid K,Lee J,Fulton IP,et al.Prostate cancer incidence and mortality rates and trends in the United States and Canada.Public Health Rep,2004(119):174.
  • 7Miller DC,Hafez KS,Stewart A,et al.Prostate carcinoma presentation,diagnosis,and staging,an update from the National Cancer Date Base.Cancer,2003(98):1169-1178.
  • 8Briasoulis E,Tolis CBergh I,et al.ESMO rninumum clinical recommendations for diagnosis,treatment and tollow-up of cancers of unlcnown primary site(CUP).Ann Oncol,2005,16 (Soppl 1):175.
  • 9International Germ Cell Cancer Collaborative Group.Internabased staging system for metastatic germ cell cancers.J Clin Oncol,1997,15(2):594-603.
  • 10de Koning HJ,Auvinen A,Berenguer Sanchez A,et al.Largescale randomised prostate cancer screening trials:Rogram performances in the European randomised screening for prostate cancer trim and the prostate,lung,colorectal and ovary cancer trial.Int J Cancer,2002,97(2):237-244.

二级参考文献47

共引文献121

同被引文献49

  • 1许良中.肿瘤病理研究的历史回顾与展望[J].中华肿瘤杂志,2004,26(8):509-512. 被引量:2
  • 2李金恒.临床个体化用药中的药物基因组学考虑[J].中国临床药理学与治疗学,2007,12(4):361-365. 被引量:17
  • 3曹博,程志,曹德品,张凤民,雷蕾.PBL教学模式在医学教学改革中的应用[J].中国高等医学教育,2007(7):1-2. 被引量:208
  • 4Dubey AK, Palaian PS, Shankar PR. Pharmacog- enomics-a new approach towards personalized medi- cine[J]. J Pak Med Assoc,2006,56(9) z426.
  • 5Evans JP, Meslin EM, Marteau TM, et al. Ge- nomics. Deflating the genomic bubble[J]. Science, 2011,331(6019) :861-862.
  • 6Flordellis CS. The emergence of a new paradigm of pharmacogenomics[J]. Pharmacogenomics,2005, 6 (5) :515-526.
  • 7Yuen MF, Lai CL. Serological markers of liver cancer[J]. Best Pract Res Clin Gastroenterol, 2005,19(1) :91-99.
  • 8Evans WE, Mcleod HL. Pharmacogenomics drug disposition, drug targets, and side effects[J]. N Engl J Med, 2003,348(6) :538-549.
  • 9Higgs JE, Andrews J, Gurwitz D, et al. Pharma- cogenetics education in British medical schools[J]. Genomic Med,2008,2(3/4):101 105.
  • 10Hamburg MA, Collins FS. The path to personal- izedmedicine[J]. N EnglJ Med, 2010,363(4):301 -304.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部